Available Guidance and Best Practices for Conducting Forced Degradation Studies

February 1, 2002

Dan W. Reynolds, PhD, Karen M. Alsante, PhD, Kevin L. Facchine, PhD, June F. Mullaney, PhD, Michael G. Motto, PhD, Todd D. Hatajik

Pharmaceutical Technology, Pharmaceutical Technology-02-02-2002, Volume 26, Issue 2

Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.